Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

Abstract

Prospective risk estimates confirm that BRCA1 and BRCA2 carriers are at high risk of developing breast, ovarian, and contralateral breast cancer. Our results confirm findings from retrospective studies that common breast cancer susceptibility alleles in combination are predictive of breast cancer risk for BRCA2 carriers.

References

Page 1

	Year	Citations
Nonparametric Estimation from Incomplete Observations Edward L. Kaplan, Paul Meier Journal of the American Statistical Association EngineeringAgingLife PredictionRare Event EstimationMortality Rates	1958	38.7K
Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study Bernard Fisher, Joseph P. Costantino, D. Lawrence Wickerham, JNCI Journal of the National Cancer Institute	1998	5.5K
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families Deborah Ford, Douglas F. Easton, Michael R. Stratton, The American Journal of Human Genetics	1998	3K
The Risk of Cancer Associated with Specific Mutations of<i>BRCA1</i>and<i>BRCA2</i>among Ashkenazi Jews Jeffery P. Struewing, Patricia Hartge, Sholom Wacholder, New England Journal of Medicine	1997	2.3K
Risks of cancer in BRCA1-mutation carriers Daniel Ford The Lancet Cancer RiskBrca1-mutation CarriersMedicinePathologyCancer Genomics	1994	1.9K
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Douglas F. Easton, Deborah Ford, D. Timothy Bishop PubMed	1995	1.6K
Prophylactic Oophorectomy in Carriers of<i>BRCA1</i>or<i>BRCA2</i>Mutations Timothy R. Rebbeck, Henry T. Lynch, Susan L. Neuhausen, New England Journal of Medicine	2002	1.5K
Association of Risk-Reducing Surgery in <emph type="ital">BRCA1</emph> or <emph type="ital">BRCA2</emph> Mutation Carriers With Cancer Risk and Mortality Susan M. Domchek JAMA	2010	1.4K
Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation Bernard Fisher, Jong‐Hyeon Jeong, Stewart Anderson, New England Journal of Medicine	2002	1.4K
Breast Cancer after Prophylactic Bilateral Mastectomy in Women with a<i>BRCA1</i>or<i>BRCA2</i>Mutation Hanne Meijers-Heijboer, Bert van Geel, Wim L.J. van Putten, New England Journal of Medicine	2001	954

Page 1